戻る
Inhibikase Therapeutics Inc (IKT)価格
IKT 株価推移チャート
IKT 収入
Inhibikase Therapeutics Inc
$1.67
1.82%
$0.03
終値： Feb 13, 16:00:00 GMT-5
$1.65
-1.19%
$-0.02
アフターマーケット：Feb 13, 20:00:00 GMT-5
主要データ
前終値
$1.64
始値
$1.64
当日レンジ
$1.64 - $1.73
52週レンジ
$1.33 - $3.32
取引高
218.2K
平均取引高
449.4K
1株当たり利益(TTM)
-1.15
配当利回り
--
時価総額
$199.4M
IKTとは何ですか？
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 15 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).